Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.45 USD | +1.70% | +1.00% | +1.56% |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 69.21 times its estimated earnings per share for the ongoing year.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.56% | 908M | C | ||
+4.71% | 32.58B | C | ||
+16.26% | 7.65B | C- | ||
+21.49% | 3.92B | B- | ||
-15.80% | 3.19B | C- | ||
-27.19% | 1.26B | B | ||
-33.58% | 1.14B | - | ||
-33.74% | 926M | - | ||
-23.93% | 859M | - | C+ | |
-14.14% | 727M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SLP Stock
- Ratings Simulations Plus, Inc.